PharmaShots | Incisive News in 3 Shots

Subscribe Now

biomarin pharmaceutical

BioMarin Pharmaceutical Reports the US FDA’s Approval of Brineura (cerliponase alfa) to Treat Neuronal Ceroid Lipofuscinosis Type 2

BioMarin Pharmaceutical Reports the US FDA’s Approval of Brineura (cerliponase alfa) to Treat Neuronal Ceroid Lipofuscinosis Type...

July 25, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us